Gilead Science Inc's antiviral drug remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday, clearing the way for broader use of the drug in more hospitals around the United States.
from Reuters: Company News https://ift.tt/2VS7tFs
via IFTTT
0 comments:
Post a Comment